Visn. Nac. Akad. Nauk Ukr. 2020.(12):31-49
https://doi.org/10.15407/visn2020.12.031
Serhiy V. Komisarenko
ORCID: https://orcid.org/0000-0002-3244-3194
Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Kyiv, Ukraine
Svitlana I. Romaniuk
ORCID: https://orcid.org/0000-0002-3900-6755
Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, Kyiv, Ukraine
PROSPECTS FOR GENE EDITING USING CRISPR/CAS, OR HOW TO MASTER THE “GENETIC SCISSORS”
Nobel Prize in Chemistry for 2020
The Nobel Prize in Chemistry in 2020 was awarded to two researchers in the field of molecular biology: French Emmanuelle Charpentier, who currently heads the Max Planck Unit for the Science of Pathogens (Berlin, Germany), and American Jennifer Doudna of the University of California (Berkeley, CA, USA) “for the development of a method for genome editing.” The press release of the Nobel Committee states that the winners have discovered one of the most powerful tools of genetic technology, CRISPR/Cas9, or so-called “genetic scissors.” This method has helped to obtain many important results in basic research. In particular, plant researchers have been able to create crops that are resistant to mold, pests and drought. In medicine, clinical trials of new methods of cancer treatment are underway, and the dream of curing hereditary diseases is about to become a reality. “Genetic scissors” have brought the life sciences to a new stage of development and are of great benefit to mankind.
Keywords: Nobel Prize in Chemistry, Emmanuelle Charpentier, Jennifer Doudna, genome editing, CRISPR/Cas9.
REFERENCES
- Chemistry. Citation Laureates 2020. https://clarivate.com/webofsciencegroup/citation-laureates/chemistry/
- Press release: The Nobel Prize in Chemistry 2020. https://www.nobelprize.org/prizes/chemistry/2020/press-release/
- Komisarenko S.V., Romanyuk S.I. Genome editing, or CRISPR/Cas9 — a panacea for many incurable diseases or the first step to a gene apocalypse? Visn. Nac. Akad. Nauk Ukr. 2020. (3): 50–77 (in Ukrainian). DOI: https://doi.org/10.15407/visn2020.03.050
- Jennifer Doudna. Wikipedia. https://en.wikipedia.org/wiki/Jennifer_Doudna
- Emmanuelle Charpentier. Wikipedia. https://en.wikipedia.org/wiki/Emmanuelle_Charpentier
- Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 2011. 471(7340): 602–607. DOI: https://doi.org/10.1038/nature09886
- Westra E.R., Semenova E., Datsenko K.A., Jackson R.N., Wiedenheft B., Severinov K., Brouns S.J. Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet. 2013. 9(9): e1003742. DOI: https://doi.org/10.1371/journal.pgen.1003742
- Ishino Y., Shinagawa H., Makino K., Amemura M., Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol. 1987. 169(12): 5429–5433. DOI: https://doi.org/10.1128/JB.169.12.5429-5433.1987
- Nakata A., Amemura M., Makino K. Unusual nucleotide arrangement with repeated sequences in the Escherichia coli K-12 chromosome. J. Bacteriol. 1989. 171(6): 3553–3556. DOI: https://doi.org/10.1128/JB.171.6.3553-3556.1989
- Groenen P.M., Bunschoten A.E., van Soolingen D., van Embden J.D. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method. Mol. Microbiol. 1993. 10(5): 1057–1065. DOI: https://doi.org/10.1111/j.1365-2958.1993.tb00976.x
- Mojica F.J., Díez-Villaseñor C., Soria E., Juez G. Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria. Mol. Microbiol. 2000. 36(1): 244–246. DOI: https://doi.org/10.1046/j.1365-2958.2000.01838.x
- Jansen R., Embden J.D., Gaastra W., Schouls L.M. Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 2002. 43(6): 1565–1575. DOI: https://doi.org/10.1046/j.1365-2958.2002.02839.x
- Mojica F.J., Díez-Villaseñor C., García-Martínez J., Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. Journal of Molecular Evolution. 2005. 60(2): 174–182. DOI: https://doi.org/10.1007/s00239-004-0046-3
- Pourcel C., Salvignol G., Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology. 2005. 151(3): 653–663. DOI: https://doi.org/10.1099/mic.0.27437-0
- Bolotin A., Quinquis B., Sorokin A., Ehrlich S.D. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology. 2005. 151(8): 2551–2561. DOI: https://doi.org/10.1099/mic.0.28048-0
- Barrangou R., Fremaux C., Deveau H., Richards M., Boyaval P., Moineau S., Romero D.A., Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007. 315(5819): 1709–1712. DOI: https://doi.org/10.1126/science.1138140
- Brouns S.J., Jore M.M., Lundgren M., Westra E.R., Slijkhuis R.J., Snijders A.P., Dickman M.J., Makarova K.S., Koonin E.V., van der Oost J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science. 2008. 321(5891): 960–964. DOI: https://doi.org/10.1126/science.1159689
- Marraffini L.A., Sontheimer E.J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science. 2008. 322(5909): 1843–1845. DOI: https://doi.org/10.1126/science.1165771
- Sontheimer E., Marraffini L. Target DNA interference with crRNA. U.S. Provisional Patent Application 61/009, 317, filed September 23, 2008; later published as US2010/0076057 (abandoned).
- Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012. 337(6096): 816–821. DOI: https://doi.org/10.1126/science.1225829
- Gasiunas G., Barrangou R., Horvath P., Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA. 2012. 109(39): E2579–E2586. DOI: https://doi.org/10.1073/pnas.1208507109
- Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science. 2013. 339(6121): 823–826. DOI: https://doi.org/10.1126/science.123203372
- Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013. 339(6121): 819–823. DOI: https://doi.org/10.1126/science.1231143
- Cho S.W., Kim S., Kim J.M., Kim J.S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 2013. 31(3): 230–232. DOI: https://doi.org/10.1038/nbt.2507
- Brown K.V. Why CRISPR-edited food may be in supermarkets sooner than you think. https://gizmodo.com/whycrispr-edited-food-may-be-in-supermarkets-sooner-th-1822025033
- Lee J., Wang F. Gene-edited baby by Chinese scientist: the opener of the Pandora’s box. Science Insights. 2018. 2018(13): e000178. DOI: https://doi.org/10.15354/si.18.co015
- Reardon S. CRISPR gene-editing creates wave of exotic model organisms. Nature. 2019. 568(7753): 441–442. DOI: https://doi.org/10.1038/d41586-019-01300-9
- Qi L.S., Larson M.H., Gilbert L.A., Doudna J.A., Weissman J.S., Arkin A.P., Lim W.A. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013. 152(5): 1173–1183. DOI: https://doi.org/10.1016/j.cell.2013.02.022
- Kungulovski G., Jeltsch A. Epigenome editing: state of the art, concepts, and perspectives. Trends Genet. 2016. 32(2): 101–113. DOI: https://doi.org/10.1016/j.tig.2015.12.001
- Pefanis E., Wang J.G., Rothschild G., Lim J., Kazadi D., Sun J.B., Federation A., Chao J., Elliott O., Liu Z.P., Economides A.N., Bradner J.E., Rabadan R., Basu U. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015. 161(4): 774–789. DOI: https://doi.org/10.1016/j.cell.2015.04.034
- Elling R., Chan J., Fitzgerald K.A. Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression. Eur. J. Immunol. 2016. 46(3): 504–512. DOI: https://doi.org/10.1002/eji.201444558
- Chen B., Gilbert L.A., Cimini B.A., Schnitzbauer J., Zhang W., Li G.W., Park J., Blackburn E.H., Weissman J.S., Qi L.S., Huang B. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell. 2013. 155(7): 1479–1491. DOI: https://doi.org/10.1016/j.cell.2013.12.001
- Hajian R., Balderston S., Tran T., deBoer T., Etienne J., Sandhu M., Wauford N.A., Chung J.Y., Nokes J., Athaiya M., Paredes J., Peytavi R., Goldsmith B., Murthy N., Conboy I.M., Aran K. Detection of unamplified target genes via CRISPR-Cas9 immobilized on a graphene field-effect transistor. Nat. Biomed. Eng. 2019. 3(6): 427–437. DOI: https://doi.org/10.1038/s41551-019-0371-x
- CRISPR’s future for point-of-care diagnostics. https://www.diagnosticsworldnews.com/news/2020/02/18/crispr%27s-future-for-point-of-care-diagnostics
- Niu Y., Shen B., Cui Y., Chen Y., Wang J., Wang L., Kang Y., Zhao X., Si W., Li W., Xiang A.P., Zhou J., Guo X., Bi Y., Si C., Hu B., Dong G., Wang H., Zhou Z., Li T., Tan T., Pu X., Wang F., Ji S., Zhou Q., Huang X., Ji W., Sha J. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell. 2014. 156(4): 836–843. DOI: https://doi.org/10.1016/j.cell.2014.01.027
- Baltimore D., Berg P., Botchan M., Carroll D., Charo R.A., Church G., Corn J.E., Daley G.Q., Doudna J.A., Fenner M., Greely H.T., Jinek M., Martin G.S., Penhoet E., Puck J., Sternberg S.H., Weissman J.S., Yamamoto K.R. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science. 2015. 348(6230): 36–38. DOI: https://doi.org/10.1126/science.aab1028
- Collins F.S. NIH Director on Human Gene Editing: ‘We Must Never Allow our Technology to Eclipse our Humanity’. https://www.discovermagazine.com/health/nih-director-on-human-gene-editing-we-must-never-allow-ourtechnology-to
- Liang P., Xu Y., Zhang X., Ding C., Huang R., Zhang Z., Lv J., Xie X., Chen Y., Li Y., Sun Y., Bai Y., Songyang Z., Ma W., Zhou C., Huang J. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell. 2015. 6(5): 363–372. DOI: https://doi.org/10.1007/s13238-015-0153-5
- Ran F.A., Hsu P.D., Lin C.Y., Gootenberg J.S., Konermann S., Trevino A.E., Scott D.A., Inoue A., Matoba S., Zhang Y., Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013. 154(6): 1380–1389. DOI: https://doi.org/10.1016/j.cell.2013.08.021
- Ma H., Marti-Gutierrez N., Park S.W., Wu J., Lee Y., Suzuki K., Koski A., Ji D., Hayama T., Ahmed R., Darby H., Van Dyken C., Li Y., Kang E., Park A.R., Kim D., Kim S.T., Gong J., Gu Y., Xu X., Battaglia D., Krieg S.A., Lee D.M., Wu D.H., Wolf D.P., Heitner S.B., Belmonte J.C.I., Amato P., Kim J.S., Kaul S., Mitalipov S. Correction of a pathogenic gene mutation in human embryos. Nature. 2017. 548(7668): 413–419. DOI: https://doi.org/10.1038/nature23305
- Second woman carrying gene-edited baby, Chinese authorities confirm. https://www.theguardian.com/science/2019/jan/22/second-woman-carrying-gene-edited-baby-chinese-authorities-confirm
- CRISPR scientist gets three years of jail time for creating gene-edited babies. https://gizmodo.com/crispr-scientistgets-three-years-of-jail-time-for-crea-1840724277
- Act now on CRISPR babies. Nature. 2019. 570(137). DOI: https://doi.org/10.1038/d41586-019-01786-3
- Citorik R.J., Mimee M., Lu T.K. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 2014. 32(11): 1141–1145. DOI: https://doi.org/10.1038/nbt.3011
- Yosef I., Manor M., Kiro R., Qimron U. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. USA. 2015. 112(23): 7267–7272. DOI: https://doi.org/10.1073/pnas.1500107112
- Stokstad E. Genetically engineered moths can knock down crop pests, but will they take off? https://www.sciencemag.org/news/2020/01/genetically-engineered-moths-can-knock-down-crop-pests-will-they-take DOI: https://doi.org/10.1126/science.abb1078
- Niu D., Wei H.J., Lin L., George H., Wang T., Lee I.H., Zhao H.Y., Wang Y., Kan Y., Shrock E., Lesha E., Wang G., Luo Y., Qing Y., Jiao D., Zhao H., Zhou X., Wang S., Wei H., G ell M., Church G.M., Yang L. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9. Science. 2017. 357(6357): 1303–1307. DOI: https://doi.org/10.1126/science.aan4187
- Gene editing spurs hope for transplanting pig organs into humans. https://www.nytimes.com/2017/08/10/health/gene-editing-pigs-organ-transplants.html
- Dash P.K., Kaminski R., Bella R., Su H., Mathews S., Ahooyi T.M., Chen C., Mancuso P., Sariyer R., Ferrante P., Donadoni M., Robinson J.A., Sillman B., Lin Z., Hilaire J.R., Banoub M., Elango M., Gautam N., Mosley R.L., Poluektova L.Y., McMillan J., Bade A.N., Gorantla S., Sariyer I.K., Burdo T.H., Young W.B., Amini S., Gordon J., Jacobson J.M., Edagwa B., Khalili K., Gendelman H.E. Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat. Commun. 2019. 10(1): 2753. DOI: https://doi.org/10.1038/s41467-019-10366-y
- Yuan M., Webb E., Lemoine N.R., Wang Y. CRISPR-Cas9 as a powerful tool for efficient creation of oncolytic viruses. Viruses. 2016. 8(3): E72. DOI: https://doi.org/10.3390/v8030072
- Miller J.F., Sadelain M. The journey from discoveries in fundamental immunology to cancer immunotherapy. Cancer Cell. 2015. 27(4): 439–449. DOI: https://doi.org/10.1016/j.ccell.2015.03.007
- White M.K., Khalili K. CRISPR/Cas9 and cancer targets: future possibilities and present challenges. Oncotarget. 2016. 7(11): 12305–12317. DOI: https://doi.org/10.18632/oncotarget.7104
- DeWitt M.A., Magis W., Bray N.L., Wang T., Berman J.R., Urbinati F., Heo S.J., Mitros T., Mu oz D.P., Boffelli D., Kohn D.B., Walters M.C., Carroll D., Martin D.I., Corn J.E. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Sci. Transl. Med. 2016. 8(360): 360ra134. DOI: https://doi.org/10.1126/scitranslmed.aaf9336
- Sanders R. UC rings out 2019 with its 20th CRISPR patent. https://news.berkeley.edu/2019/12/31/uc-rings-out-2019-with-its-20th-crispr-patent/
- Haridy R. First CRISPR therapy administered in landmark human trial. https://newatlas.com/crispr-trial-underway-vertex-gene-therapy/58643/
- The Future of CRISPR. http://www.fwreports.com/dossier/the-future-of-crispr/#.XmgL-kFR2Uk
- Mullin E. Fresh off her Nobel Prize win, Jennifer Doudna predicts what’s next for CRISPR. https://futurehuman.medium.com/fresh-off-her-nobel-prize-win-jennifer-doudna-predicts-whats-next-for-crispr-1fea0225c41d
- Pennisi E. The CRISPR craze. Science. 2013. 341(6148): 833–836. DOI: https://doi.org/10.1126/science.341.6148.833
- Gene editing like CRISPR is too important to be left to scientists alone. https://www.theguardian.com/commentisfree/2019/oct/22/gene-editing-crispr-scientists
- Chatterjee P., Jakimo N., Jacobson J.M. Minimal PAM specificity of a highly similar SpCas9 ortholog. Sci. Adv. 2018. 4(10): eaau0766. DOI: https://doi.org/10.1126/sciadv.aau0766
- Burstein D., Harrington L.B., Strutt S.C., Probst A.J., Anantharaman K., Thomas B.C., Doudna J.A., Banfield J.F. New CRISPR-Cas systems from uncultivated microbes. Nature. 2017. 542(7640): 237–241. DOI: https://doi.org/10.1038/nature21059
- Zetsche B., Gootenberg J.S., Abudayyeh O.O., Slaymaker I.M., Makarova K.S., Essletzbichler P., Volz S.E., Joung J., van der Oost J., Regev A., Koonin E.V., Zhang F. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015. 163(3): 759–771. DOI: https://doi.org/10.1016/j.cell.2015.09.038
- Abudayyeh O.O., Gootenberg J.S., Konermann S., Joung J., Slaymaker I.M., Cox D.B., Shmakov S., Makarova K.S., Semenova E., Minakhin L., Severinov K., Regev A., Lander E.S., Koonin E.V., Zhang F. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016. 353(6299): aaf5573. DOI: https://doi.org/10.1126/science.aaf5573
- Smargon A.A., Cox D.B., Pyzocha N.K., Zheng K., Slaymaker I.M., Gootenberg J.S., Abudayyeh O.A., Essletzbichler P., Shmakov S., Makarova K.S., Koonin E.V., Zhang F. Cas13b is a type VI-B CRISPR-associated RNAguided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell. 2017. 65(4): 618–630.e7. DOI: https://doi.org/10.1016/j.molcel.2016.12.023
- Yan W.X., Chong S., Zhang H., Makarova K.S., Koonin E.V., Cheng D.R., Scott D.A. Cas13d is a compact RNAtargeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol. Cell. 2018. 70(2): 327–339. DOI: https://doi.org/10.1016 / j.molcel.2018.02.028
- Harrington L.B., Burstein D., Chen J.S., Paez-Espino D., Ma E., Witte I.P., Cofsky J.C., Kyrpides N.C., Banfield J.F., Doudna J.A. Programmed DNA Destruction by Miniature CRISPR-Cas14 Enzymes. Science. 2018. 362(6416): 839–842. DOI: https://doi.org/10.1126/science.aav4294
- Anzalone A.V., Koblan L.W., Liu D.R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020. 38(7): 824–844. DOI: https://doi.org/10.1038/s41587-020-0561-9
- Strecker J., Ladha A., Gardner Z., Schmid-Burgk J.L., Makarova K.S., Koonin E.V., Zhang F. RNA-guided DNA insertion with CRISPR-associated transposases. Science. 2019. 365(6448): 48–53. DOI: https://doi.org/10.1126/science.aax9181
- Komor A.C., Kim Y.B., Packer M.S., Zuris J.A., Liu D.R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016. 533(7603): 420–424. DOI: https://doi.org/10.1038/nature17946
- Gaudelli N.M., Komor A.C., Rees H.A., Packer M.S., Badran A.H., Bryson D.I., Liu D.R. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature. 2017. 551(7681): 464–471. DOI: https://doi.org/10.1038/nature24644
- Stafforst T., Schneider M.F. An RNA-deaminase conjugate selectively repairs point mutations. Angew. Chem. Int. Ed. Engl. 2012. 51(44): 11166–11169. DOI: https://doi.org/10.1002/anie.201206489
- Reardon S. Step aside CRISPR, RNA editing is taking off. Nature. 2020. 578(7793): 24–27. DOI: https://doi.org/10.1038/d41586-020-00272-5
- Anzalone A.V., Randolph P.B., Davis J.R., Sousa A.A., Koblan L.W., Levy J.M., Chen P.J., Wilson C., Newby G.A., Raguram A., Liu D.R. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019. 576(7785): 149-157. DOI: https://doi.org/10.1038/s41586-019-1711-4
- Pennis E. Microbes’ mystery DNA helps defeat viruses – and has genome-editing potential. https://www.sciencemag.org/news/2020/11/microbes-mystery-dna-helps-defeat-viruses-and-has-genome-editing-potential
- Sharon E., Chen S.A., Khosla N.M., Smith J.D., Pritchard J.K., Fraser H.B. Functional genetic variants revealed by massively parallel precise genome editing. Cell. 2018. 175(2): 544–557.e16. DOI: https://doi.org/10.1016/j.cell.2018.08.057.
- Fan S. Everything You Need to Know About Superstar CRISPR Prime Editing https://singularityhub.com/2019/11/05/everything-you-need-to-know-about-superstar-crispr-prime-editing/